Human adipose-derived stem cells combined with high mobility group box protein 1 might be a novel therapeutic strategy for the treatment of peripheral arterial disease

Int J Cardiol. 2019 Jan 1:274:304. doi: 10.1016/j.ijcard.2018.06.085.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adipocytes
  • HMGB1 Protein*
  • Humans
  • Peripheral Arterial Disease*
  • Stem Cell Transplantation

Substances

  • HMGB1 Protein